|
Code
|
Display
|
Definition
|
|
NACHC.B2.DE113
|
RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C) |
Hepatitis C Procedures - RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C) |
|
NACHC.B2.DE114
|
Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C) |
Hepatitis C Procedures - Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C) |
|
NACHC.B2.DE115
|
Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C) |
Hepatitis C Procedures - Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C) |
|
NACHC.B2.DE116
|
Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C) |
Hepatitis C Procedures - Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C) |
|
NACHC.B2.DE117
|
Hepatitis C screening documented as performed (HIV) |
Hepatitis C Procedures - Hepatitis C screening documented as performed (HIV) |
|
NACHC.B2.DE118
|
Patient receiving antiviral treatment for Hepatitis C (HEP-C) |
Hepatitis C Procedures - Patient receiving antiviral treatment for Hepatitis C (HEP-C) |
|
NACHC.B2.DE119
|
Collection of venous blood by venipuncture |
Hepatitis C Procedures - Collection of venous blood by venipuncture |
|
NACHC.B2.DE120
|
Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver |
Hepatitis C Procedures - Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver |